WHO announced first prequalification of a tuberculosis diagnostic test
On Dec. 5, 2024, the World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for…
Biotechnology | HIV | Infectious Disease | Life Science News | Medicine | Vaccine | WHO
WHO study lists top endemic pathogens for which new vaccines are urgently needed
On Nov. 5, 2024, a World Health Organization (WHO) study published in eBioMedicine named 17 pathogens that regularly…
Tuberculosis resurges as top infectious disease killer
On Oct. 29, 2024, the World Health Organization (WHO) published a report on tuberculosis revealing that approximately 8.2…
Novo Nordisk Foundation announced USD $260 million vaccines initiative to fight deadly airborne infections
On Dec. 18, 2023, the Novo Nordisk Foundation announced it was committing up to DKK 1.8 billion (USD…
U.S. Centers for Disease Control and Prevention Tuberculosis Trials Consortium launched new TB clinical trial
On Nov. 27, 2023, the CDCï¾’s Tuberculosis Trials Consortium (TBTC) announced that it had launched an international clinical…
U.S. Preventive Services Task Force recommended screening for latent tuberculosis infection
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
Biotechnology | CDC | COVID-19 | Diagnostics | Life Science News | Vaccine
Tuberculosis in the U.S. increased slightly during 2022 although it remained lower than prepandemic years
On Mar. 24, 2023, the U.S. Centers for Disease Control and Prevention (CDC) announced that Tuberculosis (TB) in…
Abbott received FDA clearance for first commercially available lab-based blood test to help evaluate concussion
On Mar. 7, 2023, Abbott announced that it had received U.S. Food and Drug Administration clearance for what…
Tuberculosis deaths and disease increased during the COVID-19 pandemic
On Oct. 27, 2022, the World Health Organization reported that an estimated 10.6 million people fell ill with…
IAVI and Moderna partnered to tackle broad global health priorities using mRNA for vaccines and antibodies
On Apr. 7, 2022, Moderna and IAVI announced a collaboration to employ mRNA technology to meet the challenge…
NIH funded new tuberculosis research advancement centers
On Mar. 9, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced four grant awards to…
Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
Largest ever global study of tuberculosis identified genetic causes of drug resistance
On Oct. 19 , 2021, researchers at the University of Oxford, using cutting-edge genomic sequencing techniques, announced they…
Tuberculosis deaths rose for the first time in more than a decade due to the COVID-19 pandemic
On Oct. 14, 2021, the World Health Organization announced that the COVID-19 pandemic had reversed years of global…
Twist Bioscience single domain antibody TB202-3 showed potent binding to multiple strains of SARS-CoV-2
On Sept. 23, 2021, Twist Bioscience reported that its internally-discovered antibody candidate TB202-3 (CoVIC-094), demonstrated potent binding to…
The Medicines Patent Pool secured its first licence for malaria, tuberculosis and hepatitis C
On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…
U.S. FDA approved TICOVACï¾™, Pfizerï¾’s tick-borne encephalitis vaccine
On Aug. 13, 2021, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved TICOVACï¾™ (tick-borne…
Rice, Rutgers announced development of inhalable COVID-19 vaccine spray
On Jul. 7, 2021, Rice University announced a study to develop an inhalable COVID-19 vaccine. The project led…
BD announced assay for identification of COVID-19 patients at increased risks of intubation available in Europe
On Feb. 3, 2021, BD (Becton, Dickinson) announced the CE mark of BD Multitestï¾™ 6-Color TBNK Reagent with…
Abbott announced fulfillment of Federal government purchase of 150 million BinaxNOWï¾™ COVID-19 Rapid Tests
On Jan. 12, 2021, Abbott announced it had received FDA 510(k) clearance for the first rapid handheld traumatic…
Abbott received CE Mark for its COVID-19 IgG quantitative antibody blood test
On Jan. 11, 2021, Abbott announced it had received FDA 510(k) clearance for the first rapid handheld traumatic…
TB Quat Disinfectant Ready-to-Use Cleaner from 3M approved by EPA for use against SARS-CoV-2
On Nov. 10, 2020, 3M announced that its TB Quat Disinfectant Ready-to-Use Cleaner had been approved by the…
Landmark study 31/A5349 on the treatment of drug-susceptible TB
On Oct. 22, 2020, the World Health Organizationï¾’s Global TB Programme welcomed the results from a landmark study…
Landmark TB trial identified shorter-course treatment regimen
On Oct. 21, 2020, results from an international, randomized, controlled clinical trial indicated that a four-month daily treatment…
BD announce assay for immune assessment of COVID-19 patients available in Europe
On Oct. 16, 2020, BD (Becton, Dickinson) announced the CE mark and European availability of a product for…
COVID-19 | Disease | Life Science News | WHO
Global tuberculosis progress at risk during COVID-19 pandemic
On Oct. 14, 2020, the World Health Organization (WHO) announced that prior to the COVID-19 pandemic, many countries…
Oxford Immunotec announced FDA clearance of the T-SPOT.TB test for use in pediatrics over the age of two
On Sept. 29, 2020, Oxford Immunotec announced that it had received clearance from the FDA to amend the…
Oxford Immunotec announced agreement with Stop TB Partnership to access to the T-SPOTTB test for 100+ countries
On Jul. 20, 2020, Oxford Immunotec announced that it had entered into a long-term agreement to supply its…
Declines in ED visits for TBIs (including concussions) among children from contact sports
On Jul. 9, 2020, the CDC reported that after a decade of increasing rates, contact sportsï¾–related TBI ED…
Neurofilament light chain outperformed other blood tests to predict and diagnose traumatic brain injury
On Jul. 9, 2020, a study from the NIH showed that neurofilament light chain (NfL) delivered superior diagnostic…